Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Indoco Remedies Ltd (INRM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
329.15 +5.10    +1.57%
- Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE873D01024 
S/N:  INDOCO
  • Volume: 42,066
  • Bid/Ask: 328.35 / 329.15
  • Day's Range: 325.10 - 329.95
Indoco Remedies Ltd 329.15 +5.10 +1.57%

Indoco Remedies Ltd Company Profile

 
Get an in-depth profile of Indoco Remedies Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

6000

Equity Type

ORD

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Contact Information

Address Indoco House 166 CST Road
Santacruz (East) Mumbai, 400098
India
Phone 91 22 6287 1000
Fax 91 22 6287 1050

Top Executives

Name Age Since Title
Sundeep Vasant Bambolkar 62 2004 Joint MD & Executive Director
Rajiv Pritidas Kakodkar 66 2007 Independent Non-Executive Director
Divakar Madhusudan Gavaskar 79 2005 Independent Non-Executive Director
Aditi Milind Panandikar 52 2004 MD & Executive Director
Anand Madhusudan Nadkarni 64 2014 Non-Executive Director
Vasudha Vasant Kamat 70 2020 Non-Executive & Independent Director
Abhijit Yashwant Gore 57 2020 Independent Non-Executive Director
Suresh Govind Kare 84 1963 Non-Executive Chairman & Whole time Director
Ajay Mulgaokar - 2024 Independent Director
Satish Shenoy - 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INRM Comments

Write your thoughts about Indoco Remedies Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
mohd muzammil muzu
mohd muzammil muzu Aug 12, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
my target achieve
mohd muzammil muzu
mohd muzammil muzu Aug 09, 2021 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
touching 510 good results
mohd muzammil muzu
mohd muzammil muzu Aug 09, 2021 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
my target achieve
Drmini Vinodkumar
Drmini Vinodkumar May 26, 2021 6:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will touch 500 in few weeks
Samit Thakkar
Samit Thakkar May 26, 2021 6:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By which basis u r saying like this.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email